How to buy LinkDoc Technology (LDOC) stock

LinkDoc Technology is expected to go public soon. Here's what we know about the IPO — and how to buy LinkDoc Technology stock when it's available.

What we know about the LinkDoc Technology IPO

LinkDoc Technology filed a registration form with the US Securities and Exchange Commission (SEC) to go public on the NASDAQ Global Select Market as an American Depositary Share (ADS). This means that while the company is headquartered in China, you can easily buy shares using a US brokerage under the ticker symbol LDOC. Not yet an official IPO, this is one of the first steps of taking a private company public.

The exact IPO date has not been announced. Stocks are expected to open at a price of between $17.50 and $19.50. We'll update this page with more information as it becomes available.

How to buy LinkDoc Technology stock when it starts trading

Once LinkDoc Technology goes public, you'll need a brokerage account to invest. Consider opening a brokerage account today so you're ready as soon as the stock hits the market.

Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
Open your brokerage account. Complete an application with your details.
Confirm your payment details. Fund your account.
Research the stock. Find the stock by name or ticker symbol – LDOC – and research it before deciding if it's a good investment for you.
Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.

Finder's picks for buying LinkDoc Technology stock when it goes public

Go to site

Commission-free stock trading

No-cost financial planning and automated investing
$0 commission on stocks, ETFs and options
Get up to $1,000 in stock when you fund a new account within 30 days

Go to site

$200 in US stocks

Trade options, futures, options on futures, stocks, ETFs
$0 commission to close options
Get $100-$5,000 when you open an account with $5,000 to $1,000,000+

Go to site

Easy access to diverse assets

Trade stocks, bonds, options, ETFs, crypto, Treasurys, collectibles, royalties
Earn 5.1% APY on your cash
Earn a $0.18 rebate on options, with no commissions and no per-contract fees

How do similar companies perform?

It's impossible to predict how any stock will perform — and IPOs can be particularly volatile. Looking at the performance of similar companies can help you decide if now is a good time to buy LinkDoc Technology stock.

See how the following stocks are performing, and view details like market capitalization, the price-to-earnings (P/E) ratio, price/earnings-to-growth (PEG) ratio and dividend yield.

Company summary
Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations in the United States. It operates in two segments, Technology and Professional Services. The company provides data operating system data platform which provides clients single comprehensive environment to integrate and organize data from their disparate software systems; and analytics applications, a software analytics applications build for data platform to analyze clients face across clinical and quality, population health, and financial and operational use cases. It offers services expertise solutions comprising data and analytics, domain expertise and education, tech-enabled managed, and implementation services; and opportunity analysis and prioritization, data governance, data modeling and analysis, quality and process improvement strategy, cost accounting, data abstraction, and population health strategies. The company was formerly known as HQC Holdings, Inc. and changed its name to Health Catalyst, Inc. in March 2017. Health Catalyst, Inc. was founded in 2008 and is headquartered in South Jordan, Utah.
Historical performance
Stock information
- Market capitalization: $364847488
- Dividend yield: N/A%
Get more detailed information and learn how to buy HCAT.US stock
Company summary
Cerner Corporation, together with its subsidiaries, provides health care information technology solutions and tech-enabled services in the United States and internationally. It offers Cerner Millennium architecture, a person-centric computing framework, which includes clinical, financial, and management information systems that allow providers to access an individual's electronic health record (EHR) at the point of care, and organizes and delivers information for physicians, nurses, laboratory technicians, pharmacists, front- and back-office professionals, and consumers. The company also provides HealtheIntent platform, a cloud-based platform to aggregate, transform, and reconcile data across the continuum of care; and CareAware, an EHR agnostic platform that facilitates connectivity of health care devices to EHRs. In addition, it offers a portfolio of clinical and financial healthcare information technology solutions, as well as departmental and care coordination solutions. Further, the company provides tech-enabled services, such as implementation and training, remote hosting, application management, revenue cycle, support and maintenance, health care data analysis, real-world evidence, clinical process optimization, transaction processing, employer health centers, and data-driven services; and complementary hardware and devices for third parties. It serves integrated delivery networks, physician groups and networks, managed care organizations, hospitals, medical centers, free-standing reference laboratories, home health agencies, blood banks, imaging centers, pharmacies, pharmaceutical manufacturers, employers, governments, and public health organizations. The company was founded in 1979 and is headquartered in North Kansas City, Missouri. As of June 8, 2022, Cerner Corporation operates as a subsidiary of Oracle Corporation.
Historical performance
Stock information
- Market capitalization: $27915780096
- P/E ratio: 48.0608
- PEG ratio: 5.6623
- Dividend yield: 0.0114%
Get more detailed information and learn how to buy CERN.US stock
Company summary
Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative and congenital conditions, deformity, tumors, and trauma injuries; treatment options for motion preservation technologies that consist of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional solutions to treat vertebral compression fractures; and regenerative biologic products comprising of allografts and synthetic alternatives. It also offers products for the treatment of orthopedic trauma, including fracture plates, compression screws, intramedullary nails, and external fixation systems; and hip and knee joint solutions, including modular hip stems and acetabular cups, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants. In addition, the company distributes human cell, tissue, and cellular and tissue-based products. It sells its products through direct or distributor sales representatives, as well as hip and knee products through independent sales agents. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.
Historical performance
Stock information
- Market capitalization: $7102968832
- P/E ratio: 49.0374
- PEG ratio: 1.7765
- Dividend yield: N/A%
Get more detailed information and learn how to buy GMED.US stock

Compare trading platforms

Compare special offers, low fees and a wide range of types of investments among top trading platforms.

1 - 6 of 6

Name	Ratings	Available asset types	Minimum deposit	Stock trade fee	Cash sweep APY	Signup bonus
SoFi Invest® Finder Score: 4.1 / 5: ★★★★★ SoFi Invest® Finder Score: 4.1 / 5: ★★★★★	★★★★★	Stocks, Mutual funds, ETFs, Alternatives	$0	$0		Get up to $1,000 in stock when you fund a new Active Invest account	Go to site More Info		loading Fetching your data...
Tastytrade Finder Score: 4.6 / 5: ★★★★★ Tastytrade Finder Score: 4.6 / 5: ★★★★★	★★★★★	Stocks, Options, ETFs, Cryptocurrency, Futures, Treasury Bills	$0	$0	N/A	Get $100-$5,000 when you open and fund an account with $5,000 to $1,000,000+	Highly commended for Best Derivatives Trading Platform award.	Go to site More Info		loading Fetching your data...
Public.com Finder Score: 4.1 / 5: ★★★★★ Public.com Finder Score: 4.1 / 5: ★★★★★	★★★★★	Stocks, ETFs, Cryptocurrency, Art, Treasury Bills, Collectibles	$0	$0	5.1%	N/A	2.5% fee applies to all alternative asset transactions.	Go to site More Info		loading Fetching your data...
Robinhood Gold Not rated yet Robinhood Gold Not rated yet		Stocks, Options, ETFs, Cryptocurrency	$0	$0	5%	N/A	Try Robinhood Gold for 30 days risk-free upon signup and earn a 5% APY on your uninvested cash, a 3% match on IRA contributions, up to $50,000 in instant deposits and more. Accounts are auto-downgraded after the trial period.	Go to site		loading Fetching your data...
Moomoo Finder Score: 4.7 / 5: ★★★★★ Moomoo Finder Score: 4.7 / 5: ★★★★★ Exclusive	★★★★★	Stocks, Options, ETFs	$0	$0	5.10%	Choose a 1.5% match or 7 free fractional shares when you open a new account and meet funding requirements	No commission stock and ETF trading, with a chance to get a 1.5% cash reward match or 7 free fractional shares.	Go to site More Info		loading Fetching your data...
Robinhood Finder Score: 4.3 / 5: ★★★★★ Robinhood Finder Score: 4.3 / 5: ★★★★★	★★★★★	Stocks, Options, ETFs, Cryptocurrency	$0	$0	1.5%, or 5% with Robinhood Gold	Get a free stock when you successfully sign up and link your bank account.	Try Robinhood Gold for 30 days risk-free upon signup and earn a 5% APY on your uninvested cash, a 3% match on IRA contributions, up to $50,000 in instant deposits and more. Accounts are auto-downgraded after the trial period.	Go to site More Info		loading Fetching your data...

loading

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an adviser or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

More on investing

How to buy FAANG stocks

Looking to invest in tech? Here’s how to buy shares in the major tech companies, known as FAANG stocks.

Read more…

How to buy soccer stocks

A simple guide to buying stocks in your favorite European soccer team.

Read more…

Inflation stocks

Here are the stocks that benefit from inflation, as well as industries to keep an eye on to reduce the impacts of inflation on your portfolio.

Read more…

Thank you for your feedback!

How to buy Acurx Pharmaceuticals stock How to buy Membership Collective Group stock

More guides on Finder

GSD Capital review 2024
A look at GSD Capital’s highlights, limitations, fees and investment strategies.
10 best brokerage account bonuses of 2024
Explore the best bonuses for opening a new brokerage account.
11 best trading platforms for beginners 2024
These are the best trading platforms for beginners, according to Finder’s comprehensive analysis.
Methodology for robo-advisors
We rate robo-advisors across eight key categories, including ongoing costs, minimum deposit requirements, portfolio mix and more.
Public.com review 2024
A beginner-friendly investing platform with fractional shares and no commissions on stocks and ETFs.
Moomoo review 2024
Features and fees to consider before you open an account with this trading platform.
SoFi Invest® review 2024
SoFi is a commission-free platform with both active and automated investment accounts.
How to invest in the S&P 500 in 2024
What you need to know about investing in the leading indicator for the overall US stock market.
Charles Schwab review 2024
Take advantage of $0 trades and no investment minimums with this well-known broker.
Robinhood review 2024
A deep dive into the highlights and limitations of Robinhood.

Ask a Question

Click here to cancel reply.

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

How to buy LinkDoc Technology (LDOC) stock when it goes public

Here's everything we know so far about the LinkDoc Technology IPO.

What we know about the LinkDoc Technology IPO

How to buy LinkDoc Technology stock when it starts trading